Cargando…

Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects

It is reported that pulmonary fibrosis has become one of the major long-term complications of COVID-19, even in asymptomatic individuals. Currently, despite the best efforts of the global medical community, there are no treatments for COVID-induced pulmonary fibrosis. Recently, inhalable nanocarrier...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Qianyu, Zhang, Xinrui, Zhou, Dongfang, Xie, Rui, Cai, Yue, Zhang, Kehao, Sun, Xuanrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329312/ https://www.ncbi.nlm.nih.gov/pubmed/37422665 http://dx.doi.org/10.1186/s12951-023-01971-7

Ejemplares similares

Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects
por: Xu, You, et al.
Publicado: (2021)

Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
por: Taccetti, Giovanni, et al.
Publicado: (2021)

Nano based drug delivery systems: recent developments and future prospects
por: Patra, Jayanta Kumar, et al.
Publicado: (2018)

Identification and Validation of Potential Biomarkers and Pathways for Idiopathic Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis
por: Qian, Weibin, et al.
Publicado: (2021)

Recent Advances in Nano-Therapeutic Strategies for Osteoarthritis
por: Guo, Xinjing, et al.
Publicado: (2022)

Recent advances in epigenetic anticancer therapeutics and future perspectives
por: Ren, Liwen, et al.
Publicado: (2023)

Nano-liposomal dry powder inhaler of tacrolimus: Preparation, characterization, and pulmonary pharmacokinetics
por: Chougule, Mahavir, et al.
Publicado: (2007)

Gene Therapy for Cystic Fibrosis: Recent Advances and Future Prospects
por: Lomunova, M. A., et al.
Publicado: (2023)

The future of inhalation therapy in chronic obstructive pulmonary disease
por: Cazzola, Mario, et al.
Publicado: (2022)

Inhaled nano- and microparticles for drug delivery
por: El-Sherbiny, Ibrahim M., et al.
Publicado: (2015)

Recent Advances and Future Prospects of Treatment of Pulmonary Hypertension
por: Hajra, Adrija, et al.
Publicado: (2023)

Pulmonary toxicity of inhaled nano-sized cerium oxide aerosols in Sprague–Dawley rats
por: Guo, Chang, et al.
Publicado: (2019)

Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option
por: Korfei, Martina, et al.
Publicado: (2022)

Recent Advances in Idiopathic Pulmonary Fibrosis
por: Park, Sanghoon, et al.
Publicado: (2013)

The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis
por: Usmani, Omar S., et al.
Publicado: (2018)

Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions
por: Ruigrok, Mitchel J.R., et al.
Publicado: (2021)

Getting Health Hazards of Inhaled Nano/Microplastics into Focus: Expectations and Challenges
por: Cao, Guodong, et al.
Publicado: (2023)

Astragaloside IV modulates TGF‐β1‐dependent epithelial‐mesenchymal transition in bleomycin‐induced pulmonary fibrosis
por: Qian, Weibin, et al.
Publicado: (2018)

Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics
por: Chen, Tao, et al.
Publicado: (2021)

Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
por: Chennakesavulu, S., et al.
Publicado: (2018)

Metastasis‐associated protein 1 promotes epithelial‐mesenchymal transition in idiopathic pulmonary fibrosis by up‐regulating Snail expression
por: Qian, Weibin, et al.
Publicado: (2020)

Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis
por: Lu, Peng, et al.
Publicado: (2022)

Therapeutic Targets for Ankylosing Spondylitis – Recent Insights and Future Prospects
por: Perrotta, Fabio Massimo, et al.
Publicado: (2022)

Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects
por: Xiao, Zhangang, et al.
Publicado: (2018)

Recent advances in managing idiopathic pulmonary fibrosis
por: Scelfo, Chiara, et al.
Publicado: (2017)

Recent advances in understanding idiopathic pulmonary fibrosis
por: Daccord, Cécile, et al.
Publicado: (2016)

Recent advances in the genetics of idiopathic pulmonary fibrosis
por: Spagnolo, Paolo, et al.
Publicado: (2023)

Gastric Acid and Pepsin Work Together in Simulated Gastric Acid Inhalation Leading to Pulmonary Fibrosis in Rats
por: Chen, Shi, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension
por: Hadi, Dalia D., et al.
Publicado: (2023)

Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems
por: Abdellatif, Ahmed A.H., et al.
Publicado: (2021)

Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections
por: Loo, Ching-Yee, et al.
Publicado: (2023)

Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects
por: Li, Liu-Cheng, et al.
Publicado: (2017)

Mesenchymal Stem Cells in Radiation-Induced Pulmonary Fibrosis: Future Prospects
por: Chen, Yusha, et al.
Publicado: (2022)

Inhaled Antibiotics and Airway Bacterial Decolonization for Patients with Chronic Obstructive Pulmonary Disease: The Rationale and Future
por: Han, Yaopin, et al.
Publicado: (2022)

Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo
por: Sun, Ming-Chen, et al.
Publicado: (2020)

Biokinetics and clearance of inhaled gold ultrasmall-in-nano architectures
por: Mapanao, Ana Katrina, et al.
Publicado: (2020)

Inhaled beclomethasone/formoterol in idiopathic pulmonary fibrosis: a randomised controlled exploratory study
por: Wright, Caroline E., et al.
Publicado: (2017)

Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis
por: Dinh, Phuong-Uyen C., et al.
Publicado: (2020)

Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis
por: Hirani, Nikhil, et al.
Publicado: (2021)

Engineering Ferroptosis Inhibitors as Inhalable Nanomedicines for the Highly Efficient Treatment of Idiopathic Pulmonary Fibrosis
por: Guo, Mengqin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tuletr2f79k6vrukk8hn9m537u